Primary Record
CEPHALOTHIN SODIUM
- In stock
- 9,450 g
- Purity
- 98.9 %
- CAS
- 58-71-9
Compound Identifiers & Properties
- CAS
- 58-71-9
- PubChem CID
- 23675321
- SMILES
- CC(=O)OCC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)CC3=CC=CS3)SC1)C(=O)[O-].[Na+]
- Canonical SMILES
- CC(=O)OCC1=C(C(=O)[O-])N2C(=O)[C@@H](NC(=O)Cc3cccs3)[C@H]2SC1.[Na+]
Names & Synonyms
- CEPHALOTHIN SODIUM
- cefalotin sodium
- cephalothin
- Sodium cephalothin
- Keflin
- Seffin
- Cephalothin sodium salt
- Cefalothin
- Sodium cefalotin
- Sodium cephalotin
- Toricelocin
- Ceporacin
- Cepovenin
- Synclotin
- Lospoven
- Microtin
- Cefalotina sodica
- Cefalothine
- 58-71-9
- Cet Injektionsfl
- Cefalotin
- Cefalotin sodium salt
- Tokiosarl Ampullen
- Cefalothin sodium
- Averon
- Cefalothine sodium
- Cephalothin (sodium)
- Lovvalline Injektionsfl
- Keflin In Plastic Container
- Cephalotin sodium salt
- Cephalothin, Sodium
- Prestwick_971
- Keflin (TN)
- Lilly 38253
- Cefalotin sodium CRS
- Keflin N Injektionsflaschen
- Cephalothin sodium [USAN]
- sodium cefalotin(1-)
- Cefalotina sodica [Spanish]
- C22G6EYP8B
- RefChem:54748
- UNII-C22G6EYP8B
- Cephalothin sodium (USP)
- Cefalotin sodium (JP18)
- C16H15N2NaO6S2
- Cephalothin Monosodium Salt
- D0DT5E
- CHEBI:3542
- CHEMBL1632
- Monosodium Salt, Cephalothin
- Salt, Cephalothin Monosodium
- Cephalothin sodium [USAN:USP]
- MLS000069577
- SCHEMBL148785
- SPECTRUM1500166
- DTXSID30891362
- EINECS 200-394-6
- C16H15N2O6S2.Na
- C16H16N2O6S2.Na
- CEFALOTIN SODIUM [JAN]
- orb1309693
- NSC-756667
- Cephalothin (sodium) (Standard)
- ERK5-1A10
- HMS500E19
- HY-B1275R
- CEFALOTIN SODIUM [MART.]
- CID6023
- CEFALOTIN SODIUM [WHO-DD]
- MFCD00072025
- VUFGUVLLDPOSBC-XRZFDKQNSA-M
- CEPHALOTHIN SODIUM [VANDF]
- DTXCID201030513
- HMS1570O19
- HMS1920K11
- HMS2091A14
- HMS2097O19
- HMS3260J08
- HMS3714O19
- Cephalothin Sodium/Cefalotin Sodium
- HY-B1275
- Cephalothin sodium, Cefalotin sodium
- Tox21_500283
- BBF-04538
- CCG-38923
- CEPHALOTHIN SODIUM SALT [MI]
- MSK000940
- s4594
- AKOS015896088
- C16-H16-N2-O6-S2.Na
- CEFALOTIN SODIUM [EP IMPURITY]
- AC19900
- Cefalotin for impurity B identification
- CEFALOTIN SODIUM [EP MONOGRAPH]
- CS-4850
- KS-1135
- LP00283
- NSC 756667
- CEPHALOTHIN SODIUM [ORANGE BOOK]
- 7-(Thiophene-2-acetamido)cephalosporanic acid sodium salt
- CEPHALOTHIN SODIUM [USP IMPURITY]
- NCGC00093737-01
- NCGC00260968-01
- AC-15529
- AN-41764
- CEPHALOTHIN SODIUM [USP MONOGRAPH]
- CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER
- SC-25746
- SMR000058777
- Sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-(2-(thiophen-2-yl)acetamido)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Cephalothin sodium salt, 96.0-101.0%
- Cefalotin for impurity B identification CRS
- LS-150070
- 58-71-9, 153-61-7 [cephalothin]
- 7-(2-Thienylacetamido)cephalosporanic acid sodium salt
- 7-[2-Thienylacetamido]-cephalosporanic acid
- CEPHALOTHIN SODIUM W/ SODIUM CHLORIDE IN PLASTIC CONTAINER
- EU-0100283
- ST24049179
- C 4520
- C08100
- D00907
- EN300-268484
- 7-(THIOPHENE-2-ACETAMIDO)CEPHALOSPORANIC ACID SODIUM
- A1204214
- I06-1756
- Q27106126
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, monosodium salt, (6R-trans)-
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-((acetyloxy)methyl)-8-oxo-7-((2-thienylacetyl)amino)-, monosodium salt, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-, monosodiumsalt, (6R,7R)-
- Cephalothin sodium salt, BioReagent, suitable for cell culture
- Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate (ester)
- Cefalotin sodium, European Pharmacopoeia (EP) Reference Standard
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-, acetate, monosodium salt
- Cephalothin sodium, United States Pharmacopeia (USP) Reference Standard
- SODIUM (6R,7R)-3-(ACETOXYMETHYL)-8-OXO-7-((2-THIENYLACETYL)AMINO)-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLATE
- sodium (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-(thiophen-2-yl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium 7beta-(2-thienylacetamido)-3-acetoxymethyl-3-cephem-4-carboxylate
- Cefalotin for impurity B identification, European Pharmacopoeia (EP) Reference Standard
- sodium (6R, 7R)-3-acetoxymethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate
- sodium (6R,7R)-3-acetoxymethyl-7-(thien-2-ylacetamido)ceph-3-em-4-carboxylate
- (6R,7R)-3-ACETOXYMETHYL-8-OXO-7-(2-THIOPHEN-2-YL-ACETYLAMINO)-5-THIA-1-AZA-BICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE SODIUM
- 17-HYDROXY-13,17-DIMETHYL-1,2,6,7,8,13,14,15,16,17-DECAHYDROCYCLOPENTA[A]PHENANTHREN-3-ONE
- 200-394-6
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-, monosodium salt, (6R,7R)-
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-, monosodium salt, (6R-trans)-
- Cefalotin sodium; Sodium (6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[(thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-, sodium salt (1:1), (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-(hydroxymethyl)-8-oxo-7-[2-(2-thienyl)acetamido]-, acetate (ester), monosodium salt (8CI); 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-, monosodium salt, (6R,7R)- (9CI); 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[(acetyloxy)methyl]-8-oxo-7-[(2-thienylacetyl)amino]-, monosodium salt, (6R-trans)-; 38253; Averon 1; Cefalothin sodium; Cefalothine sodium; Cemastin; Cephalothin sodium; Cephalothin sodium salt; Cephation; Ceporacin; Cepovenin; Coaxin; Keflin; Lilly 38253; Losp
- Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-(2-(2-thienyl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate acetate
- Monosodium (6R,7R)-3-(hydroxymethyl)-8-oxo-7-[2-(2-thienyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate acetate (ester)
- Monosodium (6R,7R)-3-acetoxymethyl-8-oxo-7-(2-(thiophen-2-yl)acetylamino)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-[(2-thienylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-3-(acetoxymethyl)-8-oxo-7-[[2-(2-thienyl)acetyl]amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium (6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- sodium;(6R,7R)-3-(acetyloxymethyl)-8-oxo-7-[(2-thiophen-2-ylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate